Gemifloxacin
- Generic Name
- Gemifloxacin
- Brand Names
- Factive
- Drug Type
- Small Molecule
- Chemical Formula
- C18H20FN5O4
- CAS Number
- 175463-14-6
- Unique Ingredient Identifier
- OKR68Y0E4T
- Background
Gemifloxacin is a quinolone antibacterial agent with a broad-spectrum activity that is used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. It is available in oral formulations. Gemifloxacin acts by inhibiting DNA synthesis through the inhibition of both DNA gyrase and topoisomerase IV, which are essenti...
- Indication
For the treatment of bacterial infection caused by susceptible strains such as S. pneumoniae, H. influenzae, H. parainfluenzae, or M. catarrhalis, S. pneumoniae (including multi-drug resistant strains [MDRSP]), M. pneumoniae, C. pneumoniae, or K. pneumoniae.
- Associated Conditions
- Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB), Bacterial Infections, Community Acquired Pneumonia (CAP), Multidrug resistant Streptococcus pneumoniae infection, Neisseria Gonorrhoeae Infection, Bacterial rhinosinusitis
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.